SCHEMBL27587181

SCHEMBL27587181

CCCCC(O)C(CCC(C)C)C(=O)[C@H]1N=C(c2ccccc2)c2ccccc2N(C)C1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTCH1 P46531 5/20 0.43
RBPJ Q06330 3/20 0.43
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
HDAC3 O15379 9/20 0.41
HDAC1 Q13547 9/20 0.41
HDAC6 Q9UBN7 9/20 0.41
HDAC8 Q9BY41 6/20 0.40
HDAC4 P56524 5/20 0.39
HDAC7 Q8WUI4 5/20 0.39
HDAC2 Q92769 5/20 0.39
HDAC10 Q969S8 5/20 0.39
HDAC11 Q96DB2 5/20 0.39
HDAC9 Q9UKV0 5/20 0.39
HDAC5 Q9UQL6 5/20 0.39
GABRP O00591 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27567973 0.94 NOTCH1 (0.42) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27567966 0.92 HDAC3 (0.41) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27570564 0.89 NOTCH1 (0.40) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27577826 0.86 NOTCH1 (0.48) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27567906 0.86 KCNH2 (0.41) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL28747942 0.85 PSEN1 (0.43) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL28750577 0.85 NOTCH1 (0.37) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27567874 0.81 NOTCH1 (0.39) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27587101 0.78 OPRK1 (0.41) NOTCH1RBPJHDAC1GABRPGABRD
SCHEMBL27509418 0.77 HDAC3 (0.50) HDAC3HDAC1HDAC6HDAC8HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1399634-A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production BRISTOL MYERS SQUIBB PHARMA IN (US) 2003-02-26 CN disclosed